What is the Projected CAGR value of the Erectile Dysfunction Market?
Erectile Dysfunction Market is expected to grow at a CAGR of 7.4% during the forecast period 2024-2031.
Who are the key players in Erectile Dysfunction Market?
Key players are Bayer Inc, Eli Lilly and Company, Pfizer Inc., VIVUS, Inc, Coloplast A/S, Boston Scientific, Endo International, Apricus Biosciences, Teva Pharmaceuticals, Dong-A Pharma, Future Medical, Augusta Medical Systems LLC, Promedon, and Zephyr Surgical Implants.